Impact of Clinical Practice Guidelines on the Diagnostic Strategy for Carcinomas of Unknown Primary Site: a Controlled 'Before-After' Study

Clinical Oncology

Volumn 20, Issue 8, 2008, Pages 658-659

  Seve P ^a,b,c,d   Mackey, J ^d   Sawyer, M ^d   Lesimple, T ^e   de la Fouchardiere C ^f   Broussolle, C ^a,b,c   Dumontet, C ^a,b   Ray Coquard, I ^a,b,c,f  

^a UNIVERSITÉ DE LYON   (France)

^b INSERM   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITY OF ALBERTA   (Canada)

^e CENTRE EUGÈNE MARQUIS   (France)

^f CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; TAXANE DERIVATIVE; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER OF UNKNOWN PRIMARY SITE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENDOSCOPY; EVIDENCE BASED MEDICINE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; LETTER; MEDICAL AUDIT; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL RECORD REVIEW; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOGRAPHY; SCINTIGRAPHY;

GUIDELINE ADHERENCE; HUMANS; NEOPLASMS, UNKNOWN PRIMARY; PRACTICE GUIDELINES AS TOPIC;

EID: 51249107962     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.06.003     Document Type: Letter

References (5)

1. Pavlidis N., Briasoulis E., Hainsworth J., and Greco F.A. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 39 (2003) 1990-2005
2. Seve P., Sawyer M., Hanson J., Broussolle C., Dumontet C., and Mackey J.R. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study. Cancer 106 (2006) 2058-2066
3. Bugat R., Bataillard A., Lesimple T., et al. Standards, options and recommendations for the management of patient with carcinoma of unknown primary site. Bull Cancer 89 (2002) 869-875
4. Howard G.C., and Hoskin P.J. Evidence based guidelines. Still fit for purpose or past their sell by date?. Clin Oncol 19 (2007) 591-592
5. Ray-Coquard I., Philip T., Lehmann M., Fervers B., Farsi F., and Chauvin F. Impact of a clinical guidelines program for breast and colon cancer in a French cancer center. JAMA 278 (1997) 1591-1595